Stephen Shannon is currently working on a Ph.D. In biomedical sciences at the Kansas University Medical Center in Kansas City, Kansas. He performed extensive research in a neuroendocrinology lab as an undergraduate, studying the effects of brain injury on the development of post-traumatic stress disorder. Upon completion of his B.S at Wheaton College, he worked as a high school science teacher before entering his current Ph.D program. Stephen also has Cystic Fibrosis.
Stephen's experience living with CF, education in molecular biology, and his experience as a high school biology teacher gives him an acuity to write and speak concerning the issues surrounding CF to both a scientific community and a broader community unfamiliar with the science underlying the disease and its therapies.
The New England Journal of Medicine recently published findings regarding two, multinational, phase 3 studies on the administration of lumacaftor (VX-809) in combination with ivacaftor (VX-770; kayldeco). The study, ... Read more
Being informed on the science, drug developments, and public policy of CF is an excellent way to engage with the CF community and connect with your healthcare team. If ... Read more